These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26607281)

  • 1. Subglottic Squamous Cell Carcinoma: A Population-Based Study of 889 Cases.
    Marchiano E; Patel DM; Patel TD; Patel AA; Xue YE; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):315-21. PubMed ID: 26607281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal Verrucous Carcinoma: A Population-Based Analysis.
    Dubal PM; Svider PF; Kam D; Dutta R; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):799-805. PubMed ID: 26124268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal spindle cell carcinoma: A population-based analysis of incidence and survival.
    Dubal PM; Marchiano E; Kam D; Dutta R; Kalyoussef E; Baredes S; Eloy JA
    Laryngoscope; 2015 Dec; 125(12):2709-14. PubMed ID: 25994520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases.
    Patel TD; Echanique KA; Yip C; Hsueh WD; Baredes S; Park RCW; Eloy JA
    Laryngoscope; 2019 Aug; 129(8):1822-1827. PubMed ID: 30536822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
    Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
    Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Nodal Level Distribution on Survival in Oral Cavity Squamous Cell Carcinoma: A Population-Based Study.
    Marchiano E; Patel TD; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Jul; 155(1):99-105. PubMed ID: 26980921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal Neuroendocrine Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Ghosh R; Dutta R; Dubal PM; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):966-72. PubMed ID: 26183520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphous low-grade adenocarcinoma of the head and neck: A population-based study of 460 cases.
    Patel TD; Vazquez A; Marchiano E; Park RC; Baredes S; Eloy JA
    Laryngoscope; 2015 Jul; 125(7):1644-9. PubMed ID: 25877006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of patients with subglottic squamous cell carcinoma.
    MacNeil SD; Patel K; Liu K; Shariff S; Yoo J; Nichols A; Fung K; Garg AX
    Curr Oncol; 2018 Dec; 25(6):e569-e575. PubMed ID: 30607125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).
    Milano AF
    J Insur Med; 2024 Jul; 51(2):92-110. PubMed ID: 39266004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of patients with subglottic squamous cell carcinoma based on the SEER database.
    Yang F; He L; Rao Y; Feng Y; Wang J
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S70-S80. PubMed ID: 34716102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal adenosquamous carcinoma: A population-based perspective.
    Dubal PM; Unsal AA; Echanique KA; Vazquez A; Reder LS; Baredes S; Eloy JA
    Laryngoscope; 2016 Apr; 126(4):858-63. PubMed ID: 26452061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary subglottic cancer.
    Dahm JD; Sessions DG; Paniello RC; Harvey J
    Laryngoscope; 1998 May; 108(5):741-6. PubMed ID: 9591557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.